Effect of age on glucose and lipid metabolism

年龄对糖脂代谢的影响

基本信息

  • 批准号:
    8325719
  • 负责人:
  • 金额:
    $ 30.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-10 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Aging is a major risk factor for the development of type 2 diabetes (T2DM). Skeletal muscle is the main site of insulin-stimulated glucose disposal and aging is characterized by muscle insulin resistance. It has been suggested that the insulin resistance of aging results from an age-related accumulation of intramyocellular lipids which impair insulin action. However, the molecular basis for the accumulation of intramyocellular fat remains unknown. AMP-activated protein kinase (AMPK) is an energy-sensing enzyme whose activation results in increased fatty acid oxidation. Recently, it has been established that aging leads to reduced AMPK activity in muscle. Using the insulin clamp technique with muscle biopsies, and a primary human muscle cell culture system, we plan to test the hypothesis that age-related declines in AMPK signaling are responsible for the decreases in fat oxidation, excessive intramyocellular lipid accumulation, and insulin resistance that occur in aging human muscle. The following Specific Aims are proposed: Aim 1) To determine whether reduced AMPK signaling in muscle from older subjects, in vivo, is associated with lower fat oxidation rates and insulin resistance, and whether physical activity improves glucose homeostasis in older subjects by upregulating AMPK signaling in muscle; Aim 2) To determine whether age-related declines in AMPK signaling in old myotubes cultured in vitro increases the susceptibility to fat-induced insulin resistance; and Aim 3) To examine whether the age-related reductions in fat oxidation and insulin action in old myotubes can be reversed by upregulating AMPK activity. PUBLIC HEALTH RELEVANCE: Aging is associated with a high risk for developing type 2 diabetes and impaired glucose tolerance, a pre- diabetic state. However, the reason why older subjects are at high risk for developing these abnormalities in glucose (sugar) metabolism is not known. In this study we will test whether reduced activity of a protein called AMPK is responsible for the abnormal glucose metabolism that occurs in older subjects, and whether restoring the function of this protein improves glucose metabolism in these individuals. If positive, our findings could help design new ways to prevent type 2 diabetes in the elderly.
描述(由申请人提供):衰老是2型糖尿病(T2 DM)发展的主要风险因素。骨骼肌是胰岛素刺激的葡萄糖代谢的主要场所,衰老以肌肉胰岛素抵抗为特征。已经表明,衰老的胰岛素抵抗是由于与年龄相关的肌细胞内脂质的积累损害了胰岛素的作用。然而,肌细胞内脂肪积累的分子基础仍然未知。AMP活化蛋白激酶(AMPK)是一种能量敏感酶,其活化导致脂肪酸氧化增加。最近,已经确定衰老导致肌肉中AMPK活性降低。使用胰岛素钳技术与肌肉活检,和原代人肌肉细胞培养系统,我们计划测试的假设,年龄相关的下降AMPK信号是负责减少脂肪氧化,过度的肌细胞内脂质积累,和胰岛素抵抗,发生在老化的人肌肉。提出了以下具体目的:目的1)确定老年受试者体内肌肉中AMPK信号传导的减少是否与较低的脂肪氧化速率和胰岛素抗性相关,以及体力活动是否通过上调肌肉中AMPK信号传导来改善老年受试者的葡萄糖稳态;目的2)研究体外培养的老年肌管中AMPK信号的年龄相关性下降是否增加了脂肪诱导的胰岛素抵抗的易感性;和目的3)检测是否可以通过上调AMPK活性来逆转衰老肌管中脂肪氧化和胰岛素作用的年龄相关性降低。 公共卫生相关性:衰老与发展2型糖尿病和糖耐量受损(一种糖尿病前期状态)的高风险相关。然而,老年受试者发生葡萄糖(糖)代谢异常的风险较高的原因尚不清楚。在这项研究中,我们将测试一种名为AMPK的蛋白质的活性降低是否是导致老年受试者葡萄糖代谢异常的原因,以及恢复这种蛋白质的功能是否会改善这些个体的葡萄糖代谢。如果结果是肯定的,我们的研究结果可以帮助设计新的方法来预防老年人的2型糖尿病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicolas Musi其他文献

Nicolas Musi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicolas Musi', 18)}}的其他基金

Single nuclei RNA-seq to map adipose cellular populations and senescet cells in older subjects
单核 RNA-seq 绘制老年受试者的脂肪细胞群和衰老细胞图谱
  • 批准号:
    10361123
  • 财政年份:
    2022
  • 资助金额:
    $ 30.51万
  • 项目类别:
Single nuclei RNA-sequencing to map adipose cellular populations and senescent cells in older subjects
单核 RNA 测序绘制老年受试者的脂肪细胞群和衰老细胞图谱
  • 批准号:
    10815427
  • 财政年份:
    2022
  • 资助金额:
    $ 30.51万
  • 项目类别:
Biospecimen Core
生物样本核心
  • 批准号:
    10701910
  • 财政年份:
    2021
  • 资助金额:
    $ 30.51万
  • 项目类别:
Biospecimen Core
生物样本核心
  • 批准号:
    10376629
  • 财政年份:
    2021
  • 资助金额:
    $ 30.51万
  • 项目类别:
Molecular Transducers of Physical Activity Consortium Adult Clinical Center
体力活动联盟成人临床中心分子传感器
  • 批准号:
    10842074
  • 财政年份:
    2016
  • 资助金额:
    $ 30.51万
  • 项目类别:
Molecular Transducers of Physical Activity Clinical Centers (U01) - Cedars -Sinai Medical Center
身体活动分子传感器临床中心 (U01) - Cedars -Sinai Medical Center
  • 批准号:
    10782038
  • 财政年份:
    2016
  • 资助金额:
    $ 30.51万
  • 项目类别:
Molecular Transducers of Physical Activity Clinical Centers (U01) - UT Health San Antonio Clinical Center
身体活动分子传感器临床中心 (U01) - UT Health 圣安东尼奥临床中心
  • 批准号:
    10531636
  • 财政年份:
    2016
  • 资助金额:
    $ 30.51万
  • 项目类别:
University of Texas Adult Clinical Center
德克萨斯大学成人临床中心
  • 批准号:
    10391627
  • 财政年份:
    2016
  • 资助金额:
    $ 30.51万
  • 项目类别:
University of Texas Adult Clinical Center
德克萨斯大学成人临床中心
  • 批准号:
    10265119
  • 财政年份:
    2016
  • 资助金额:
    $ 30.51万
  • 项目类别:
University of Texas Adult Clinical Center
德克萨斯大学成人临床中心
  • 批准号:
    9246912
  • 财政年份:
    2016
  • 资助金额:
    $ 30.51万
  • 项目类别:

相似海外基金

Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
  • 批准号:
    2867610
  • 财政年份:
    2023
  • 资助金额:
    $ 30.51万
  • 项目类别:
    Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
  • 批准号:
    BB/W009633/1
  • 财政年份:
    2022
  • 资助金额:
    $ 30.51万
  • 项目类别:
    Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 30.51万
  • 项目类别:
    Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
  • 批准号:
    459043
  • 财政年份:
    2021
  • 资助金额:
    $ 30.51万
  • 项目类别:
    Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2020
  • 资助金额:
    $ 30.51万
  • 项目类别:
    Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10561642
  • 财政年份:
    2019
  • 资助金额:
    $ 30.51万
  • 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 30.51万
  • 项目类别:
    Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
  • 批准号:
    2243045
  • 财政年份:
    2019
  • 资助金额:
    $ 30.51万
  • 项目类别:
    Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10359032
  • 财政年份:
    2019
  • 资助金额:
    $ 30.51万
  • 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
  • 批准号:
    428988
  • 财政年份:
    2019
  • 资助金额:
    $ 30.51万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了